ZoomMed inc.

ZoomMed inc.

May 24, 2006 11:38 ET

ZoomMed Signs a License and Distribution Agreement with Emergis Inc.

MONTREAL, QUEBEC--(CCNMatthews - May 24, 2006) - M. Yves Marmet, President and Chief Executive Officer of ZoomMed Inc. (TSX VENTURE:ZMD), is very proud to announce that the corporation signed a license and distribution agreement with Emergis Inc.

Mr. Marmet declared: "This transaction marks another important step in our partnership development strategy to facilitate the marketing of our product. This agreement aims to integrate ZoomMed's "ZRx Prescriber" to the Emergis therapeutic advisor data base, known as "SanteXpert™", which includes different functionalities such as drug interactions, counter-indications, pathological and medical classifications and treatment alternatives".

The ZRx Prescriber allows doctors to write prescriptions and send them electronically to pharmacists, and allows pharmacists to view those prescriptions on-line and confirm them electronically. The ZRx Prescriber provides an interactive access to the patient's pharmacological profile and prescription help tools. It will also allow doctors to electronically validate, with insurance companies, whether the patient prescribed medication is covered. In fact, it is a system which aims at improving information accessibility and collaboration among the different actors of this sector, thus creating a more secure and efficient prescription drug management, which will benefit patients, government, doctors, pharmacists, insurers and pharmaceutical companies.

As previously announced, ZoomMed signed on February 9, 2006, a commercial collaboration agreement with ADN Medical www.adnmedical.com, which has been offering computer services to doctors in Quebec for more than 15 years. With this agreement, ZoomMed has direct access to the actual clients of ADN Medical, that is to say 4,500 doctors throughout Quebec, which will propel the deployment of the "ZRx Prescriber"

About Emergis Inc.

For further information on Emergis Inc., visit their Web site: http://www.emergis.com/en/

About ZoomMed Inc.

For further information on Zoommed Inc and the "Prescriber ZRx" visit our website: www.zoommed.com.

The TSX Venture Exchange has neither approved nor accepts any responsibility with respect to the veracity or exactitude of this press release.

Contact Information

  • ZoomMed inc.
    Yves Marmet
    President and Chief Executive Officer
    (450) 678-5457